UniSuper Management’s Bio-Techne TECH Stock Holding History

UniSuper Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$750K	Sell	10,616 -17,538	-62%	-$947K	﹤0.01%	537
2026 Q1	$1.47M	Buy	28,154 +592	+2%	+$35.5K	0.01%	516
2025 Q4	$1.62M	Sell	27,562 -8,513	-24%	-$517K	0.01%	510
2025 Q3	$2.01M	Buy	36,075 +3,580	+11%	+$192K	0.01%	497
2025 Q2	$1.67M	Buy	32,495 +2,072	+7%	+$104K	0.01%	521
2025 Q1	$1.78M	Buy	30,423 +3,600	+13%	+$244K	0.01%	488
2024 Q4	$1.93M	Buy	26,823 +4,489	+20%	+$330K	0.01%	469
2024 Q3	$1.79M	Buy	22,334 +2,653	+13%	+$199K	0.01%	483
2024 Q2	$1.41M	Buy	19,681 +5,942	+43%	+$437K	0.01%	509
2024 Q1	$967K	Buy	13,739 +11,667	+563%	+$835K	0.01%	551
2023 Q4	$160K	Sell	2,072 -252	-11%	-$16.6K	﹤0.01%	570
2023 Q3	$158K	Sell	2,324 -319	-12%	-$25.2K	﹤0.01%	508
2023 Q2	$216K	Buy	+2,643	New	+$212K	﹤0.01%	457

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UniSuper Management's TECH Position: Q2 2026 in Review

UniSuper Management reduced its Bio-Techne (TECH) stake by 62% in Q2 2026, selling an estimated $947K and leaving 10,616 shares worth $750K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

UniSuper Management first reported a position in TECH in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.01M in Q3 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

UniSuper Management held 10,616 shares of Bio-Techne worth $750K as of Q2 2026.
UniSuper Management sold 17,538 Bio-Techne shares in Q2 2026, an estimated $947K.
Bio-Techne made up ﹤0.01% of UniSuper Management's portfolio in Q2 2026, its #537 holding.
UniSuper Management first reported a position in Bio-Techne in Q2 2023 and has held it in 13 quarters since.
UniSuper Management's Bio-Techne position peaked at $2.01M in Q3 2025.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.